Literature DB >> 10974229

Lipoprotein lipase gene polymorphism, cholesterol subfractions and myocardial infarction in large samples of the general population.

S R Holmer1, C Hengstenberg, B Mayer, A Döring, H Löwel, S Engel, H W Hense, M Wolf, G Klein, G A Riegger, H Schunkert.   

Abstract

OBJECTIVE: Genetic variants of the lipoprotein lipase gene have been associated with dyslipidemia and coronary artery disease. However, data have been inconsistent and are mainly based on selected predominantly male patient groups.
METHODS: We evaluated the influence of the HindIII restriction fragment length polymorphism on lipid levels in the general population (1361 participants of a large population-based survey from Augsburg, Germany; 50% women) as well as the association of this polymorphism with the risk of myocardial infarction (MI; genotype frequencies in 1159 patients with documented MI under 60 years of age).
RESULTS: In the population-based survey, a highly significant association between the frequent H2H2 genotype and unfavorable cholesterol subfraction levels was observed in men and in postmenopausal women whereas no significant association was observed in premenopausal women (uni- and multivariate analysis). Such unfavorable lipid levels in homozygotes for the H2 allele may be expected to be associated with a 19-25% increased risk to suffer from myocardial infarction (MI). Nevertheless, genotype and allele frequencies in the general population were not different from those in patients with previous MI (H2H2 genotype frequency 51.3% vs. 53.2%, respectively; P=0.63).
CONCLUSION: This large study shows that the H2H2 genotype of the lipoprotein lipase gene polymorphism is associated with unfavorable lipid levels. Estrogen status may modulate this association in women. The effects of the genotype on lipid levels were apparently not strong enough to reveal a significant association with MI.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10974229     DOI: 10.1016/s0008-6363(00)00131-0

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  10 in total

1.  Association of lipoprotein lipase and apolipoprotein C-III genes polymorphism with acute myocardial infarction in diabetic patients.

Authors:  Tarek A Abd El-Aziz; Rasha H Mohamed; Reem M Hashem
Journal:  Mol Cell Biochem       Date:  2011-04-17       Impact factor: 3.396

2.  The novel genetic variant predisposing to coronary artery disease in the region of the PSRC1 and CELSR2 genes on chromosome 1 associates with serum cholesterol.

Authors:  Nilesh J Samani; Peter S Braund; Jeanette Erdmann; Anika Götz; Maciej Tomaszewski; Patrick Linsel-Nitschke; Cother Hajat; Massimo Mangino; Christian Hengstenberg; Klaus Stark; Andreas Ziegler; Mark Caulfield; Paul R Burton; Heribert Schunkert; Martin D Tobin
Journal:  J Mol Med (Berl)       Date:  2008-07-23       Impact factor: 4.599

3.  Deficiency of choresteryl ester transfer protein and gene polymorphisms of lipoprotein lipase and hepatic lipase are not associated with longevity.

Authors:  Yasymichi Arai; Nobuyoshi Hirose; Ken Yamamura; Susumu Nakazawa; Ken-Ichirou Shimizu; Michiyo Takayama; Yoshinori Ebihara; Satoki Homma; Yasuyuki Gondo; Yukie Masui; Hiroki Inagaki
Journal:  J Mol Med (Berl)       Date:  2003-02-11       Impact factor: 4.599

4.  Lipoprotein lipase gene sequencing and plasma lipid profile.

Authors:  Dilek Pirim; Xingbin Wang; Zaheda H Radwan; Vipavee Niemsiri; John E Hokanson; Richard F Hamman; M Michael Barmada; F Yesim Demirci; M Ilyas Kamboh
Journal:  J Lipid Res       Date:  2013-11-09       Impact factor: 5.922

Review 5.  Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.

Authors:  Eva Boes; Stefan Coassin; Barbara Kollerits; Iris M Heid; Florian Kronenberg
Journal:  Exp Gerontol       Date:  2008-11-17       Impact factor: 4.032

6.  Antiretroviral treatment-induced dyslipidemia in HIV-infected patients is influenced by the APOC3-related rs10892151 polymorphism.

Authors:  Gerard Aragonès; Carlos Alonso-Villaverde; Pedro Pardo-Reche; Anna Rull; Raúl Beltrán-Debón; Esther Rodríguez-Gallego; Laura Fernández-Sender; Jordi Camps; Jorge Joven
Journal:  BMC Med Genet       Date:  2011-09-22       Impact factor: 2.103

7.  Resequencing of LPL in African Blacks and associations with lipoprotein-lipid levels.

Authors:  Dilek Pirim; Xingbin Wang; Zaheda H Radwan; Vipavee Niemsiri; Clareann H Bunker; M Michael Barmada; M Ilyas Kamboh; F Yesim Demirci
Journal:  Eur J Hum Genet       Date:  2015-01-28       Impact factor: 4.246

8.  Associations between LPL gene polymorphisms and coronary artery disease: evidence based on an updated and cumulative meta-analysis.

Authors:  Wen-Qi Ma; Ying Wang; Xi-Qiong Han; Yi Zhu; Nai-Feng Liu
Journal:  Biosci Rep       Date:  2018-02-19       Impact factor: 3.840

9.  Age Stratification in Genetic Variation of Lipoprotein Lipase in Metabolic Syndrome Javanese Ethnics of Indonesia.

Authors:  Rosdiana Mus; Ahmad Hamim Sadewa; Pramudji Hastuti; Anggelia Puspasari; Citra Maharani; Ika Setyawati
Journal:  Open Access Maced J Med Sci       Date:  2019-10-13

Review 10.  Dyslipidemia: Genetics, lipoprotein lipase and HindIII polymorphism.

Authors:  Marcos Palacio Rojas; Carem Prieto; Valmore Bermúdez; Carlos Garicano; Trina Núñez Nava; María Sofía Martínez; Juan Salazar; Edward Rojas; Arturo Pérez; Paulo Marca Vicuña; Natalia González Martínez; Santiago Maldonado Parra; Kyle Hoedebecke; Rosanna D'Addosio; Clímaco Cano; Joselyn Rojas
Journal:  F1000Res       Date:  2017-11-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.